Physician profile
Gary B Bokinsky
NPI 1831152909
$12,014.31
in general payments reported to CMS, 2019-2025
52 companies · $1,908 in 2025
The $1,908 reported for 2025 was more than what 79% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,581 · 2020: $1,070 · 2021: $1,914 · 2022: $2,160 · 2023: $2,075 · 2024: $1,306 · 2025: $1,908.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,289.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,289.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dendreon Pharmaceuticals LLC | $1,873.84 | 2019-2025 | Provenge |
| Janssen Biotech, INC. | $1,224.11 | 2019-2025 | Erleada |
| Astellas Pharma US INC | $899.35 | 2019-2025 | Xtandi, Myrbetriq |
| Bayer Healthcare Pharmaceuticals INC. | $874.78 | 2019-2025 | |
| Abbvie INC. | $797.65 | 2019-2025 | Lupron Depot, Botox |
| Pfizer INC. | $750.49 | 2019-2025 | |
| Endo Pharmaceuticals INC. | $695.40 | 2019-2024 | Xiaflex, Aveed |
| Sumitomo Pharma America, INC. | $664.94 | 2023-2025 | Gemtesa, Orgovyx |
| Blue Earth Diagnostics | $360.64 | 2019-2025 | Posluma |
| Antares Pharma, INC. | $355.37 | 2019-2023 | Tlando, Xyosted, Nocdurna |
| Urogen Pharma, INC. | $283.77 | 2020-2025 | Jelmyto |
| Progenics Pharmaceuticals, INC. | $273.93 | 2021-2025 | Pylarify |
| Novartis Pharmaceuticals Corporation | $245.10 | 2023-2025 | |
| Amgen INC. | $235.92 | 2019-2022 | |
| Urovant Sciences INC | $227.11 | 2021-2022 |
Show all 52 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo USA, INC. | $184.55 | 2024-2025 | Xiaflex, Aveed |
| Ambu INC. | $180.02 | 2022-2024 | |
| Neotract INC. | $157.23 | 2020 | |
| Halozyme INC | $121.53 | 2023 | |
| Dornier Medtech America, INC | $109.15 | 2023 | Dornier Medtech |
| Accord Healthcare, INC. | $103.45 | 2022-2025 | |
| Coloplast Corp | $86.35 | 2021 | |
| Travere Therapeutics, INC. | $82.39 | 2019-2021 | |
| C. R. Bard, INC. & Subsidiaries | $81.86 | 2019-2023 | Surestep Foley Tray System Bardex I.C. Complete Care Foley Catheter, Bard Urinary Drainage Bag |
| Astrazeneca Pharmaceuticals LP | $80.25 | 2020-2022 | |
| Merck Sharp & Dohme LLC | $79.20 | 2020-2024 | Keytruda, Welireg, Lynparza |
| Bioprotect Medical, INC. | $74.82 | 2025 | Bioprotect Balloon Implant System |
| Sun Pharmaceutical Industries INC. | $69.03 | 2023-2025 | Yonsa |
| Tolmar Pharmaceuticals, INC. | $63.62 | 2021-2022 | |
| Rochester Medical Corporation | $58.41 | 2019-2020 | |
| Myovant Sciences INC. | $56.40 | 2021-2022 | |
| Genzyme Corporation | $51.43 | 2019 | |
| Cardinal Health 414 LLC | $49.06 | 2024-2025 | |
| Ferring Pharmaceuticals INC. | $48.37 | 2019-2025 | Adstiladrin |
| Foundation Medicine, INC. | $47.25 | 2019-2021 | |
| Inspire Medical Systems, INC. | $47.02 | 2025 | Inspire |
| Boston Scientific Corporation | $41.72 | 2019-2023 | Rezum Generator |
| Olympus America INC. | $41.20 | 2025 | Itind System |
| Teleflex LLC | $39.77 | 2024-2025 | Barrigel, Urolift |
| Allergan, INC. | $37.61 | 2019 | |
| Mission Pharmacal Company | $33.70 | 2019-2020 | |
| Axonics, INC. | $30.57 | 2021 | |
| Abc Home Medical Supply, INC. | $29.07 | 2025 | |
| Tempus Ai, INC | $26.21 | 2024 | Xt Cdx |
| Clovis Oncology, INC. | $24.27 | 2020 | |
| Tolmar, INC. | $24.05 | 2023 | |
| Myriad Genetic Laboratories, INC. | $22.57 | 2021 | |
| Verity Pharmaceuticals INC. | $19.45 | 2023 | Trelstar |
| Photocure INC | $13.44 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $13.29 | 2023 | Seglentis |
| Clarus Therapeutics INC. | $12.35 | 2021 | |
| Metuchen Pharmaceuticals | $11.25 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gary Bokinsky listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.